Background. Maintenance antipsychotic medication is the mainstay of relapse prevention in
patients with schizophrenia. Long acting depot antipsychotics were developed to promote …

Long-acting depot antipsychotics were developed specifically to promote treatment
adherence (compliance) and they are a valuable option for patients requiring maintenance …

Abstract Treatment with long-acting depot antipsychotics may yield beneficial effects with
regard to long-term adherence and long term outcomes in patients with schizophrenia …

Background: Since 2002, a second-generation depot antipsychotic has been available that
potentially combines the advantages of depot administration and the favorable aspects of …

In many countries fewer than 20% of individuals with schizophrenia receive depot
antipsychotic medication. Frequently stated reasons are psychiatrist's, patient's and relative's …

Antipsychotic depots are less frequently prescribed than oral compounds. In an
experimental study involving N= 106 psychiatrists we studied how much more effective with …

Objective: This study examines attitudes of mental health professionals about the use and
usefulness of depot antipsychotic medications and determines similarities and differences in …

These guidelines for depot antipsychotic treatment in schizophrenia were developed during
a two-day consensus conference held on July 29 and 30, 1995 in Siena, Italy. Depot …

In spite of their well known advantages, depot antipsychotics are seldom prescribed in the
treatment of schizophrenia. A frequently stated reason is the patient's objection to depot …

BackgroundDepot antipsychotic medication is used widely in the treatment and prophylaxis
of severe mental illness. AimsTo review the literature on patient and nurse satisfaction with …